Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6121455 | Journal of Clinical Virology | 2012 | 6 Pages |
Abstract
Of the 29 laboratories that participated the first year, 27 were able to correctly identify all of the virus types in the panel. Fifty-one PHLs participated in the program the second year when pandemic H1N1 was added, and 45 were able to correctly detect, type and subtype all of the viruses in the panel. In the program's third year, 60 laboratories participated; 58 correctly detected and subtyped all of the viruses in the panel. Annual surveys of assay techniques showed that the PHLs had shifted their extraction methods and PCR-thermocycler instrumentation to meet FDA-approved methods. The degradation study revealed that frozen viral stocks were stable for at least 30Â months, thus allowing ample time to prepare and pre-test panels.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Michael D. Popowich, Scott J. Brunt, Ryan T. Bennett, Kirsten St. George,